东方生物

- 688298

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2026  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016 
东方生物(688298) 利润表
单位:万元
报表日期2026-03-312025-12-312025-09-302025-06-302025-03-31
一、营业总收入25,626.4894,737.9967,181.2140,307.9819,195.18
营业收入25,626.4894,737.9967,181.2140,307.9819,195.18
二、营业总成本34,630.71134,178.6289,868.2058,210.6730,869.48
营业成本14,634.3356,089.9439,208.9025,144.5113,943.42
营业税金及附加478.141,987.461,057.31750.31291.96
销售费用4,294.2619,098.8613,386.398,863.664,414.44
管理费用9,270.0240,230.7027,124.0918,087.028,988.92
财务费用1,753.22-6,309.51-7,263.70-6,002.50-2,641.84
研发费用4,200.7423,081.1616,355.2011,367.665,872.58
资产减值损失----------
公允价值变动收益303.85-159.66498.78499.26-155.65
投资收益709.84868.15552.03348.43245.94
其中:对联营企业和合营企业的投资收益-47.24-279.37-207.86-127.38-15.14
汇兑收益----------
三、营业利润-9,281.63-58,224.48-23,421.66-17,894.80-12,348.64
加:营业外收入0.2877.6829.9827.983.20
减:营业外支出1.24202.5880.63-555.8512.03
其中:非流动资产处置损失----------
四、利润总额-9,282.59-58,349.38-23,472.31-17,310.98-12,357.46
减:所得税费用587.531,391.14-354.8995.00-280.45
五、净利润-9,870.12-59,740.52-23,117.42-17,405.98-12,077.01
归属于母公司所有者的净利润-9,384.31-57,359.82-21,263.21-16,309.78-11,545.25
少数股东损益-485.81-2,380.70-1,854.21-1,096.20-531.76
六、每股收益
基本每股收益(元/股)-0.4900-2.9800-1.1000-0.8400-0.5700
稀释每股收益(元/股)-0.4900-2.9800-1.1000-0.8400-0.5700
七、其他综合收益-495.54-2,878.27-2,179.01-2,182.65-782.12
八、综合收益总额-10,365.66-62,618.79-25,296.43-19,588.63-12,859.13
归属于母公司所有者的综合收益总额-9,879.85-60,238.09-23,442.22-18,492.43-12,327.37
归属于少数股东的综合收益总额-485.81-2,380.70-1,854.21-1,096.20-531.76
下载全部历史数据到excel中 返回页顶